The weekly litigation news digest is live. Subscribe now

Dpp-Iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation - EP2285410

The patent EP2285410 was granted to Boehringer Ingelheim on Sep 26, 2018. The application was originally filed on Apr 2, 2009 under application number EP09728065A. The patent is currently recorded with a legal status of "Revoked".

EP2285410

BOEHRINGER INGELHEIM
Application Number
EP09728065A
Filing Date
Apr 2, 2009
Status
Revoked
Nov 11, 2022
Publication Date
Sep 26, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ISARPATENTJun 26, 2019ISARPATENTADMISSIBLE
GALENICUM HEALTH SLUJun 25, 2019TORREJON NIETOADMISSIBLE
HEXALJun 25, 2019ELKINGTON AND FIFEADMISSIBLE
HGFJun 25, 2019-ADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP1852108
INTERNATIONAL-SEARCH-REPORTWO2006135693
INTERNATIONAL-SEARCH-REPORTWO2007041053
INTERNATIONAL-SEARCH-REPORTWO2007078726
INTERNATIONAL-SEARCH-REPORTWO2008113000

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents